Date | Time | Source | Headline | Symbol | Company |
08/14/2023 | 7:00AM | GlobeNewswire Inc. | Spectral MD Holdings, Ltd. (“Spectral MD” or the “Company”) ISO 13485 Certification Received for AI-Driven DeepView® Wound Imaging System | NASDAQ:RCLF | Rosecliff Acquisition Corporation I |
06/22/2023 | 4:13PM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:RCLF | Rosecliff Acquisition Corporation I |
06/20/2023 | 4:16PM | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:RCLF | Rosecliff Acquisition Corporation I |
06/20/2023 | 7:00AM | Business Wire | Spectral MD Holdings, Ltd (“Spectral MD” or the “Company”) Completion of ISO 13485 Certification Audit | NASDAQ:RCLF | Rosecliff Acquisition Corporation I |
06/13/2023 | 5:05PM | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:RCLF | Rosecliff Acquisition Corporation I |
06/13/2023 | 7:00AM | Business Wire | Spectral MD Holdings, Ltd (“Spectral MD” or the “Company”) Announces Publication of Peer Reviewed Proof-of-Concept Study Evaluating DeepView® Technology in Journal of Burn Care & Research | NASDAQ:RCLF | Rosecliff Acquisition Corporation I |
05/18/2023 | 4:08PM | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:RCLF | Rosecliff Acquisition Corporation I |
05/18/2023 | 7:00AM | Business Wire | Spectral MD Announces Podium Presentation at 2023 American Burn Association Annual Conference | NASDAQ:RCLF | Rosecliff Acquisition Corporation I |
05/12/2023 | 4:08PM | Edgar (US Regulatory) | Quarterly Report (10-q) | NASDAQ:RCLF | Rosecliff Acquisition Corporation I |
05/12/2023 | 4:06PM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:RCLF | Rosecliff Acquisition Corporation I |
05/09/2023 | 11:45AM | Business Wire | Wensheng Fan, CEO of Spectral MD, Discusses How Artificial Intelligence (AI) Can Revolutionize the Standard of Care in Burn Wound Diagnostics | NASDAQ:RCLF | Rosecliff Acquisition Corporation I |
05/09/2023 | 8:30AM | Business Wire | Wengshen Fan, CEO of Spectral MD, Discusses How Artificial Intelligence (AI) Can Revolutionize the Standard of Care in Burn Wound Diagnostics | NASDAQ:RCLF | Rosecliff Acquisition Corporation I |
04/18/2023 | 4:55PM | Business Wire | Spectral MD Holdings, Ltd. $4.0 Million Grant Award from the Medical Technology Enterprise Consortium | NASDAQ:RCLF | Rosecliff Acquisition Corporation I |
04/18/2023 | 4:05PM | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:RCLF | Rosecliff Acquisition Corporation I |
04/17/2023 | 9:23AM | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:RCLF | Rosecliff Acquisition Corporation I |
04/17/2023 | 9:22AM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:RCLF | Rosecliff Acquisition Corporation I |
04/11/2023 | 9:07AM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:RCLF | Rosecliff Acquisition Corporation I |
04/11/2023 | 7:15AM | Business Wire | Spectral MD Holdings, Ltd., an FDA Breakthrough Designated company focused on Artificial Intelligence driven Medical Diagnostic Solutions, to be Listed on Nasdaq Through Business Combination with Rosecliff Acquisition Corp I | NASDAQ:RCLF | Rosecliff Acquisition Corporation I |
04/05/2023 | 4:39PM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:RCLF | Rosecliff Acquisition Corporation I |
02/14/2023 | 4:28PM | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:RCLF | Rosecliff Acquisition Corporation I |
02/14/2023 | 9:59AM | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:RCLF | Rosecliff Acquisition Corporation I |
02/14/2023 | 7:43AM | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:RCLF | Rosecliff Acquisition Corporation I |
02/03/2023 | 4:34PM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:RCLF | Rosecliff Acquisition Corporation I |
12/22/2022 | 5:23PM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:RCLF | Rosecliff Acquisition Corporation I |
11/21/2022 | 6:03AM | Edgar (US Regulatory) | Proxy Soliciting Materials (revised) (prer14a) | NASDAQ:RCLF | Rosecliff Acquisition Corporation I |
11/10/2022 | 4:05PM | Edgar (US Regulatory) | Quarterly Report (10-q) | NASDAQ:RCLF | Rosecliff Acquisition Corporation I |
11/09/2022 | 6:19AM | Edgar (US Regulatory) | Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a) | NASDAQ:RCLF | Rosecliff Acquisition Corporation I |
08/12/2022 | 4:47PM | Edgar (US Regulatory) | Quarterly Report (10-q) | NASDAQ:RCLF | Rosecliff Acquisition Corporation I |
05/13/2022 | 4:31PM | Edgar (US Regulatory) | Quarterly Report (10-q) | NASDAQ:RCLF | Rosecliff Acquisition Corporation I |
03/31/2022 | 6:45AM | Edgar (US Regulatory) | Annual Report (10-k) | NASDAQ:RCLF | Rosecliff Acquisition Corporation I |